Danaher (DHR) is nearing a nearly $10B deal to buy medical technology company Masimo (MASI), two years after activist investor Politan Capital Management overhauled the device maker’s board, The Financial Times’ Sujeet Indap and Oliver Barnes report. A deal for the California-based Masimo could be announced as early as Tuesday provided it does not hit any last-minute snags, according to people familiar with the matter. A deal could value Masimo at about $9.9B.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DHR:
- M&A News: Masimo Shares Rally 38% on Danaher’s $10B Deal Talks
- Danaher Announces Retirement of Board Member Jessica Mega
- Private Markets: Nvidia, Microsoft consider new investment in OpenAI
- Danaher price target raised to $270 from $250 at Deutsche Bank
- Danaher price target raised to $251 from $247 at Baird